Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1997-03-14
1999-01-05
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 149, 424 165, 424 169, 534 10, 534 14, 568 8, 568 10, 568 17, 556 18, 564161, A61K 5100, C07F 902, C07F 500, C07C23300
Patent
active
058558675
ABSTRACT:
A compound and method of making a compound for use as a diagnostic or therapeutic pharmaceutical comprises at least one functionalized hydroxyalkyl phosphine donor group and one or more sulfur or nitrogen donor and a metal combined with the ligand.
REFERENCES:
patent: 4439196 (1984-03-01), Higuchi
patent: 4446224 (1984-05-01), DeCant, Jr. et al.
patent: 4447233 (1984-05-01), Mayfield
patent: 4475196 (1984-10-01), La Zor
patent: 4486194 (1984-12-01), Ferrara
patent: 4487603 (1984-12-01), Harris
patent: 4795626 (1989-01-01), Deutsch et al.
patent: 4959217 (1990-09-01), Sanders et al.
patent: 5167616 (1992-12-01), Haak et al.
patent: 5169383 (1992-12-01), Gyory et al.
patent: 5225182 (1993-07-01), Sharma
patent: 5635158 (1997-06-01), Mazzi et al.
Abrams et al., "Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide . . . " J Nucl Med 31:2022-2028, (1990).
Abrams et al. "Synthesis and crystal and molecular structure of a technetium-hydralazino complex . . . " Inorg Chim Acta 173:133-135, (1990).
Chianelli et al. "99mTc-interleukin-2: a new radiopharmaceutical for the in vivo detection of lymphocytic infiltration" J Nucl Biol Med 38:476, (1994).
Deutsch, "Aspects of the chemistry of technetium phosphine complexes" Radiochim Acta 63:195-197, (1993).
Ellis et al., "Water-soluble tris (hydroxymethyl) phosphine complexes with nickel, palladim and platinum . . ." Inorg Chem 31:3026-3033, (1992).
Fritzberg et al., "Specific and stable labeling of antibodies with 99mTc with a dimide dithiolate chelating agent" Proc. Natl. Acad. Sci., USA 85:4025-4029, (1988).
Gustavson et al., "Synthesis of a new class of Tc-chelating agents . . ." Tetrahedron Lett, vol. 32, No. 40, pp. 5485-5488 (1991).
Jurisson et al., "Coordination compounds in nuclear medicine" Chem Rev 93:1137-1156, (1993).
Kelly et al., Technetium-99m-Tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging J Nucl Med 34:222-227 (1993).
Knight et al., "Thrombus imaging with 99mTc synthetic peptides based upon the binding domain of a monoclonal antibody . . ." J Nucl Med 35:282-288, (1994).
Lister-James et al., "A structure-activity-relationship (SAR) study of somatostatin receptor-binding peptides . . ." J Nucl Med, 35:257-258P, (1994).
Marmion et al., "Radiopharmaceutical development of TechneScan Q-12" J Nucl Biol Med 38:455-456, (1994).
Meares et al., "Chelate radiochemistry: cleavable linkers lead to altered levels of radioactivity in the liver" Int J Cancer 2:99-102, (1988).
Maina et al., "Synthesis, radiochemical and biological evaluation of
Nock et al., "99mTc-N4-Lys-Biotin, a new biotin derivative useful for pretargeted avidin-biotin immunoscintigraphy. . ." J Nucl Biol Med 38:460, (1994).
Nowotnik and Nunn, "Technetium SPECT agents for imaging heart and brain" DN and P 5:174-183, (1992).
Parker, "Tumour targeting with radiolabeled macrocycle-antibody conjugates" Chem. Soc. Rev. 19:271-291, (1990).
Pasqualini et al., "Bis(dithiocarbamato)nitrido technetium-99m radid-pharmaceuticals: a class of neutral myocardial. . ." J. Nucl. Med. 35:334-340 (1994).
Rao et al., "Kinetics and mechanism of reactions of S-protected dithiol monoaminemonamide (MAMA) ligands with technetium" Nucl Med Biol, 19:889-895, (1992).
Troutner, "Chemical and physical properties of radionuclides" Nucl Med Biol 14:171 (1987).
Volkert et al., "Therapeutic radionuclides: production and decay property considerations" J Nucl Med 32:174-185, (1991).
Wilbur, "Radiohalogenation of proteins: an overview of radionuclides, labeling methods and reagents for conjugate labeling" Bioconj Chem 3:433-470, (1992).
Archer et al. (1995) in Technetium and rhenium in chemistry and nuclear medicine, editors Nicolini et al., Servizi Grafici Editoriali, Padova, 173.
Bandoli et al. (1984) An isothiocyanato complex of Technetium (II). Spectroelectrochemical and single-crystal x-ray.. Inorg. Chem., 23:2898-2901. O.sub.2 !+ type ions. Inorg. Chem., 4:797-803.
Berning et al., (1996) In vitro and in vivo characterization of a 99mTc complex with tris(hydroxymethyl)phosphine (THP) J. Nucl. Med. Biol., 23:617-622.
Betz et al., (1994) in Basic Neurochem. Molecular Cell, Raven Press Ltd., NY, 5th ed., pp. 681-699.
Blessing (1995) An empirical correction for absorption anisotropy Acta Crystallogr., Sect. A, 51:33-38.
Brem et al. (1993) Polymers as controlled drug delivery devised for the treatment of malignant brain tumors. Eur. J. Pharm. Biopharm., 39:2-7.
Clarke and Podbielski (1987) Medical diagnostic imaging with complexes of 99mTc. Coord. Chem. Rev., 78:253-331.
DeRosch et al., (1992) Kit development for the Tc-99m myocardial imaging agent. J. Nucl. Med., 33:850.
Greenwood and Earnshaw, (1993) in Chemistry of the elements, Pergamon Press, New York, Chapter 12, pp. 546-636. phosphino!ethane: human biodistribution . . . J. Nucl. Med., 34:30-38.
Hnatowich, (1990) Antibody radiolabeling, problems and promises. Nucl. Med. Biol., 17:49-55.
Ichimura et al., (1984) Technetium electrochemistry. 2. Electro-chemical and spectroelectrochemical studies. . Inorg. Chem., 23:1272-1278.
Jain et al., (1993) Biokinetics of technetium-99m-tetrofosmin: myocardial perfusion imaging agent. . J. Nucl. Med., 34:1254-1259.
Jurisson et al., (1993) Coordination compounds in nuclear medicine. Chem. Rev., 93:1137-1156.
Katti (1996) Recent advances in the chemistry of water-soluble phosphines-catalytic and biomedical aspects. Current Science, 70:219-225.
Katti et al., (1995) Coordination chemistry of phosphorus (III) and phosphorus(V) hydrazides. Chem. Soc.Rev., 97-107.
Libson et al., (1983) Synthesis, characterization, and electro-chemical properties of tertiary diphosphine . . . Inorg. Chem., 22(12), 1695-1704.
Marmion et al., (1995) in Technetium and Rhenium in Chemistry and Nuclear Medicine-4; Nicolini, M et al. eds; Servizi Grafici Editoriali, Padova, pp. 253-258.
Mayer and Kaska, (1994) Sterochemical control of transition metal complexes by polyphosphine ligands. Chem. Rev., 94:1239-1272.
Maina et al. (1994) Synthesis, radiochemical and biological evaluation of
Orpen et al., (Harrison et al.) (1989) Water soluble, zero-valent, platinum-, palladium-, and nickel . . . Chem. Soc. Chem. Commun., 1096-1097.
Pardridge (1992) Blood-brain barrier and new approaches to brain drug delivery. West J. Med., 156(3) 281-286.
Pardridge (1992) Recent developments in peptide drug delivery to the brain. Pharm. Toxicol., 71(1)3-10. vector-mediated peptide drug delivery. Proc. Natl. Acad. Sci. USA, 90(7)2618-2622.
Reddy et al., (1996) Synthesis and characterization of dioxorhenium complexes derived from water-soluble diphosphine . . . J. Chem. Soc., Dalton Trans., 4459-4462.
Reddy et al., (1996) Hydroxymethyl bis(phosphines) and their palladium (II) and platinum (II) complexes . . . J. Chem. Soc., Dalton Trans., pp. 1301-1304.
Reddy et al., (1996) Chemistry in environmentally benign media. Synthesis and characterization of rhenium (V) . . . Inorg. Chem., 35:1753-1757.
Reddy et al., (1995) Chemistry in environmentally benign media Part 1. Synthesis and characterization . . Inorg. Chim. Acta., 240:367-370.
Refosco et al., (1993) Co-ordination of (o-aminophenyl)diphenyl-phosphine in complexes . . . J. Chem. Soc. Dalton Trans., 605-618.
Sheldrick (1990) Phase annealing in SHELX-90: direct methods for larger structures. Acta Cyrstallogr., A46:467.
Smith et al., (1996) New advances in the synthesis of water-soluble triphosphine and the development of tripodally . . . J. Chem. Soc. Chem. Commun., 2557-2558.
Tisato et al., (1995) Syntheses and structural characterizations of six-coordinatoe Oxo-M(V) complexes . . . Inorg. Chem., 34:1779-1787.
Vanderheyden et al., (1985) Comparison of the chemical and biological properties . . . Inorg. Chem., 24:1666-1673.
Vanderheyden et al. (1984) Synthesis and characterization of cationic technetium complexes of 1,2-Bis(dimethylphosphino)ethane . . . Inorg. Chem., 23:3184-3191.
Berning Douglas E.
Karra Srinivasa Rao
Katti Kattesh V.
Ketring Alan R.
Smith C. Jeffrey
Hartley Michael G.
Hollinden Gary E.
The Curators of the University of Missouri
LandOfFree
Hydroxymethyl phosphine compounds for use as diagnostic and ther does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxymethyl phosphine compounds for use as diagnostic and ther, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxymethyl phosphine compounds for use as diagnostic and ther will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-859562